1 |
Almonte M, Ferreccio C, Gonzales M (2011). Risk factors for high-risk human papillomavirus infection and cofactors for high-grade cervical disease in Peru. Int J Gynecol Cancer, 21, 1654-63.
DOI
ScienceOn
|
2 |
American Cancer Society (2009). What Are the Risk Factors for Cervical Cancer? Available at http://www.cancer.org/cancer/cervicalcancer/detailedguide/cervical-cancer-risk-factors. Accessed July 14, 2010.
|
3 |
Belinson S, Smith JS, Myers E, et al (2008). Descriptive evidence that risk profiles for cervical intraepithelial neoplasia 1, 2, and 3 are unique. Cancer Epidemiol Biomarkers Prev, 17, 2350-5.
DOI
ScienceOn
|
4 |
Barbosa LC, da Silva ID, Correa JC, Ribalta JC (2011). Survivin and telomerase expression in the uterine cervix of women with human papillomavirus-induced lesions. Int J Gynecol Cancer, 21, 15-21.
DOI
ScienceOn
|
5 |
Bibbo M, Klump WJ, DeCecco J, Kovatich AJ (2002). Procedure for immunocytochemical detection of P16INK4A antigen in thin-layer, liquid-based specimens. Acta Cytol, 46, 25-9.
DOI
ScienceOn
|
6 |
Boone JD, Erickson BK, Huh WK (2012). New insights to cervical cancer screening. J Gynecol Oncol, 23, 282-7.
DOI
ScienceOn
|
7 |
Borbely AA, Murvai M, Konya J et al (2006). Effects of human papillomavirus type 16 oncoproteins on survivin gene expression. J Gen Virol, 87, 287-94.
DOI
ScienceOn
|
8 |
Branca M, Giorgi C, Santini D, et al (2005). Survivin as a marker of cervical intraepithelial neoplasia and high-risk human papillomavirus and a predictor of virus clearance and prognosis in cervical cancer. Am J Clin Pathol, 124, 113-21.
DOI
ScienceOn
|
9 |
Branca M, Ciotti M, Giorgi C et al (2008). Predicting high-risk human papillomavirus infection, progression of cervical intraepithelial neoplasia, and prognosis of cervical cancer with a panel of 13 biomarkers tested in multivariate modeling. Int J Gynecol Pathol, 27, 265-73.
|
10 |
Castle PE, Cox JT, Schiffman M WC, Solomon D (2008). Factors influencing histologic confirmation of high-grade squamous intraepithelial lesion cytology. Obstet Gynecol, 112, 637-45.
DOI
ScienceOn
|
11 |
de Boer MA, Vet JN, Aziz MF et al (2006). Human papillomavirus type 18 and other risk factors for cervical cancer in Jakarta, Indonesia. Int J Gynecol Cancer, 16, 1809-14.
DOI
ScienceOn
|
12 |
Engberts MK, Verbruggen BS, Boon ME, van Haaften M, Heintz AP (2007). Candida and dysbacteriosis: a cytologic, population-based study of 100,605 asymptomatic women concerning cervical carcinogenesis. Cancer, 111, 269-74.
DOI
ScienceOn
|
13 |
Gadducci A, Barsotti C, Cosio S, Domenici L, Riccardo GA (2011). Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature. Gynecol Endocrinol, 27, 597-604.
DOI
ScienceOn
|
14 |
Gillet E, Meys JFA, Verstraelen H, et al (2012). Association between bacterial vaginosis and cervical intraepithelial neoplasia: systematic review and metaanalysis. PLoS One, 7, 45201.
DOI
|
15 |
Kim K, Kim JJ, Kim SM, No JH, Kim YB (2012). Prevalence and determinants of high-risk human papillomavirus infection in women with high socioeconomic status in Seoul, Republic of Korea. Asian Pac J Cancer Prev, 13, 269-73.
과학기술학회마을
DOI
ScienceOn
|
16 |
Hellberg D, Stendahl U (2005). The biological role of smoking, oral contraceptive use and endogenous sexual steroid hormones in invasive squamous epithelial cervical cancer. Anticancer Res, 25, 3041-6.
|
17 |
Jensen KE, Schmiedel S, Norrild B et al (2013). Parity as a cofactor for high-grade cervical disease among women with persistent human papillomavirus infection: a 13-year follow-up. Br J Cancer, 108, 234-9.
DOI
ScienceOn
|
18 |
Kim JW, Song SH, Jin CH, et al (2012). Factors affecting the clearance of high-risk human papillomavirus infection and the progression of cervical intraepithelial neoplasia. J Int Med Res, 40, 486-96.
DOI
|
19 |
Li F (2005). Role of survivin and its splice variants in tumorigenesis. Br J Cancer, 92, 212-6.
|
20 |
Mita AC, Mita MM, Nawrocki ST, Giles FJ (2008). Survivin:key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin Cancer Res, 14, 5000-5.
DOI
ScienceOn
|
21 |
Poomtavorn Y, Suwannarurk K, Thaweekul Y, Maireang K (2011). Risk factors for high-grade cervical intraepithelial neoplasia in patients with atypical squamous cells of undetermined significance (ASC-US) Papanicolaou smears. Asian Pac J Cancer Prev, 12, 235-8.
|
22 |
Roeters AM, Boon ME, van Haaften M, et al (2010). Inflammatory events as detected in cervical smears and squamousintraepithelial lesions. Diagn Cytopathol, 38, 85-93.
|
23 |
Tan GC, Norlatiffah S, Sharifah NA et al (2010). Immunohistochemical study of p16 INK4A and survivin expressions in cervical squamous neoplasm. Indian J Pathol Microbiol, 53, 1-6.
DOI
ScienceOn
|
24 |
WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre) (2010). Human Papillomavirus and Related Cancers in Indonesia. Summary Report 2010. Accessed 5 February 2013.
|